MONECO ADVISORS, LLC

Position in GSK — GSK plc

CIK 1765690 FAIRFIELD, CT

Position in GSK

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$3,185,406

-$372,638 QoQ

Shares Held

60,767

-5.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

#195

of 1,033 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MONECO ADVISORS, LLC holds $43,364,399 across 12 Drug Manufacturers - General names. GSK ranks #5 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	64,501	$16,381,318
2	LLY	ELI LILLY & Co	6,143	$7,368,099
3	ABBV	AbbVie Inc.	22,944	$5,773,628
4	PFE	Pfizer Inc	170,546	$4,106,747
5	GSK	GSK plc This page	60,767	$3,185,406
6	MRK	Merck & Co., Inc.	18,894	$2,427,879
7	AMGN	Amgen Inc	4,401	$1,593,690
8	BMY	Bristol Myers Squibb Co	11,852	$682,912

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,185,406	60,767	-5.7%	Shares	Sole	2026-08-11
2026-03-31	$3,558,044	64,469	-1.2%	Shares	Sole	2026-05-08
2025-12-31	$3,198,683	65,226	+532.5%	Shares	Sole	2026-02-04
2025-09-30	$445,109	10,313	-0.1%	Shares	Sole	2025-11-05
2025-06-30	$396,480	10,325	+2.7%	Shares	Sole	2025-08-13
2025-03-31	$389,337	10,050	-5.4%	Shares	Sole	2025-08-15
2024-12-31	$359,236	10,622	-13.8%	Shares	Sole	2025-08-15
2024-09-30	$503,559	12,318	+6.4%	Shares	Sole	2024-10-25
2024-06-30	$445,599	11,574	-5.0%	Shares	Sole	2024-07-19
2024-03-31	$522,370	12,185	-2.0%	Shares	Sole	2024-07-19
2023-12-31	$460,766	12,433	+2.9%	Shares	Sole	2024-03-13
2023-09-30	$438,153	12,087	+39.8%	Shares	Sole	2024-03-13
2023-06-30	$308,036	8,643	+3.8%	Shares	Sole	2024-03-13
2023-03-31	$296,345	8,329	+28.3%	Shares	Sole	2023-05-12
2022-12-31	$228,199	6,494	—	Shares	Sole	2023-01-30
No filing history on record for this holder in this stock.